ANTICORPS ANTI-C-MET, CONJUGUE D'ANTICORPS ANTI-C-MET-MEDICAMENT CYTOTOXIQUE ET LEUR UTILISATION PHARMACEUTIQUE

• 收藏
• 分享

专利权人:

SUZHOU SUNCADIA BIOPHARMACEUTICALS CO., LTD.;SUZHOU SUNCADIA BIOPHARMACEUTICALS CO.; LTD.;SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.;JIANGSU HENGRUI MEDICINE CO., LTD.

发明人:

LIU, JIAJIAN,ZHANG, LIANSHAN,TAO, WEIKANG,FU, YAYUAN,ZHANG, LING,MA, DONG,CUI, DONGBING,WANG, YALI,XU, JIANYAN,LIANG, JINDONG,ZHANG, YING,JIANG, GUIYANG,QIU, JUNZHUAN,SUN, ZIYONG,ZHA, JIPING,WEI, JING

申请号：

CA2982777

公开号：

CA2982777A1

申请日:

2016.04.07

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

Provided are an anti-c-Met antibody or antigen binding fragment, and an anti-c-Met antibody-cytotoxic drug conjugate, wherein the antibody or antigen binding fragment is a chimeric antibody or a humanized antibody. Also provided are a pharmaceutical composition containing a humanized anti-c-Met antibody or antigen binding fragment, antibody-cytotoxic drug conjugate, or a pharmaceutically acceptable salt or solvent compound thereof, applied in the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/